
#121 How Do They Get Paid? The FTC's Use of Monetary Relief for Deterrence and Compensation
The use of monetary relief-- also called disgorgement-- historically was used by the FTC for deterrence and compensation of consumers. Now that the Supreme Court has ruled that the FTC lacks authority...
28 Jun 202135min

#120 What Advice Do You Have for a Young Lawyer? Words of Wisdom from Our Guests
In many past episodes of Our Curious Amalgam we asked our guests what career advice they would give to their younger selves. As hosts Alicia Downey, John Roberti, and Jessica Watters discovered, the a...
21 Jun 202132min

#119 Is This Game Over? Competition Law Implications of the Super League.
The Super League didn't last long but the post-game analysis continues. What are the competition law issues raised and do they remain relevant? Dwayne Bach, sports and esports law expert, joins Christ...
14 Jun 202128min

#118 What's The Role Of Journalism In Antitrust?: A Conversation With Leah Nylen
People often read more from journalists than from lawyers to learn about antitrust. But what roles does journalism itself play in antitrust, in terms of the development and practice of the law? Leah N...
7 Jun 202136min

#117 Can It Be Resolved? The Use of Mediators to Settle Antitrust Class Actions.
Mediation is a tool that litigants can use to resolve disputes. What are the advantages of using a mediator, particularly in high-stakes antitrust class actions? Judge Vaughn Walker, retired Chief Jud...
31 Mai 202146min

#116 Can Non-Competes Be Procompetitive?: An Economist's View
By its name, a non-compete agreement restricts competition. But can non-competes be procompetitive or otherwise designed to minimize the competition concerns? Dr. Paul Wong, Economist and Director at ...
24 Mai 202133min

#115 Are We Witnessing a Revolution? Putting the Debate Over Antitrust Reform Into Context.
Accepted norms and standards are increasingly being questioned in the antitrust world as calls for reform grow louder. Why is this groundswell of dissent from traditional doctrine occurring now, and w...
17 Mai 202131min

#114 What Are the Generic and Biosimilar Industries Worried About? Current Competition Law Issues Impacting the Sector.
Generics and biosimilars are an important part of the pharmaceutical landscape in Europe. What are the competition law issues faced by suppliers of those products? Adrian van den Hoven, Director Gener...
10 Mai 202140min



















